Latest News
May 21, 2021
Not intended for U.S. and UK Media
Positive CHMP opinion for Bayer’s new symptomatic chronic heart failure treatment vericiguat
May 19, 2021
Not intended for U.S. and UK Media - ASCO Annual Meeting 2021:
Long-term data on Vitrakvi™ (larotrectinib) confirm sustained clinical benefit of greater than four years in patients with TRK fusion cancer regardless of tumor type and age
May 17, 2021
Not intended for U.S. and UK Media - Late-Breaking Data from exploratory analysis of Phase III FIDELIO-DKD study presented at the American College of Cardiology’s (ACC) 70th Annual Scientific Session (ACC.21)
Finerenone has potential to reduce the risk of new onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes
Our Stories
